DK3619237T3 - Antistoffer mod karcinoembryonalt antigen til cancerterapi og -diagnosticering - Google Patents
Antistoffer mod karcinoembryonalt antigen til cancerterapi og -diagnosticering Download PDFInfo
- Publication number
- DK3619237T3 DK3619237T3 DK18722497.7T DK18722497T DK3619237T3 DK 3619237 T3 DK3619237 T3 DK 3619237T3 DK 18722497 T DK18722497 T DK 18722497T DK 3619237 T3 DK3619237 T3 DK 3619237T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnosis
- antibodies against
- cancer therapy
- carcinoembryonal antigen
- carcinoembryonal
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000011275 oncology therapy Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17305498.2A EP3398967A1 (en) | 2017-05-04 | 2017-05-04 | Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis |
| PCT/EP2018/061385 WO2018202794A1 (en) | 2017-05-04 | 2018-05-03 | Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3619237T3 true DK3619237T3 (da) | 2024-04-08 |
| DK3619237T5 DK3619237T5 (da) | 2024-09-02 |
Family
ID=58707444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18722497.7T DK3619237T5 (da) | 2017-05-04 | 2018-05-03 | Antistoffer mod karcinoembryonalt antigen til cancerterapi og -diagnosticering |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11427646B2 (da) |
| EP (2) | EP3398967A1 (da) |
| AU (1) | AU2018262648B2 (da) |
| CA (1) | CA3062233A1 (da) |
| DK (1) | DK3619237T5 (da) |
| ES (1) | ES2975798T3 (da) |
| FI (1) | FI3619237T3 (da) |
| HU (1) | HUE066183T2 (da) |
| PL (1) | PL3619237T3 (da) |
| PT (1) | PT3619237T (da) |
| WO (1) | WO2018202794A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025257185A1 (en) | 2024-06-11 | 2025-12-18 | Abcely | Humanized anti-human-carcinoembryonic antigen antibody |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9014932D0 (en) | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
| FR2861255B1 (fr) | 2003-10-24 | 2006-02-17 | Centre Nat Rech Scient | Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications. |
| EP2478110B1 (en) | 2009-09-16 | 2016-01-06 | Immunomedics, Inc. | Class i anti-cea antibodies and uses thereof |
| US20140242081A1 (en) * | 2011-07-18 | 2014-08-28 | Micromet Ag | Dosing regimens for treatment of cea-expressing cancers |
-
2017
- 2017-05-04 EP EP17305498.2A patent/EP3398967A1/en not_active Withdrawn
-
2018
- 2018-05-03 AU AU2018262648A patent/AU2018262648B2/en active Active
- 2018-05-03 EP EP18722497.7A patent/EP3619237B1/en active Active
- 2018-05-03 ES ES18722497T patent/ES2975798T3/es active Active
- 2018-05-03 PT PT187224977T patent/PT3619237T/pt unknown
- 2018-05-03 US US16/609,878 patent/US11427646B2/en active Active
- 2018-05-03 CA CA3062233A patent/CA3062233A1/en active Pending
- 2018-05-03 HU HUE18722497A patent/HUE066183T2/hu unknown
- 2018-05-03 WO PCT/EP2018/061385 patent/WO2018202794A1/en not_active Ceased
- 2018-05-03 PL PL18722497.7T patent/PL3619237T3/pl unknown
- 2018-05-03 DK DK18722497.7T patent/DK3619237T5/da active
- 2018-05-03 FI FIEP18722497.7T patent/FI3619237T3/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2975798T3 (es) | 2024-07-15 |
| HUE066183T2 (hu) | 2024-07-28 |
| PL3619237T3 (pl) | 2024-06-24 |
| US11427646B2 (en) | 2022-08-30 |
| AU2018262648B2 (en) | 2024-08-08 |
| PT3619237T (pt) | 2024-03-05 |
| US20200055952A1 (en) | 2020-02-20 |
| WO2018202794A1 (en) | 2018-11-08 |
| EP3398967A1 (en) | 2018-11-07 |
| EP3619237A1 (en) | 2020-03-11 |
| FI3619237T3 (fi) | 2024-04-19 |
| EP3619237B1 (en) | 2024-01-17 |
| AU2018262648A1 (en) | 2019-11-07 |
| CA3062233A1 (en) | 2018-11-08 |
| DK3619237T5 (da) | 2024-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261422A (en) | Therapeutic and diagnostic methods for cancer | |
| DK3458478T3 (da) | Anti-pd-1- og anti-lag3-antistoffer til cancerbehandling | |
| IL283625A (en) | Diagnostic methods and compositions for cancer immunotherapy | |
| HUE061874T2 (hu) | Anti-PD-1 antitestek és besugárzás kombinált alkalmazása a rák kezelésére | |
| DK3458102T3 (da) | Anti-cmet-antistoflægemiddelkonjugater og fremgangsmåder til anvendelse deraf | |
| DK3504242T3 (da) | Anti-ox40-antistoffer og anvendelse deraf | |
| EP3256156C0 (en) | IMMUNOTHERAPY VACCINE AND ANTIBODY-BASED COMBINATION THERAPY | |
| PH12016501618A1 (en) | Anti-dll3 antibodies and drug conjugates for use in melanoma | |
| HUE046505T2 (hu) | Antitestkészítmények daganatkezelésre | |
| DK3294770T3 (da) | Terapeutiske og diagnostiske fremgangsmåder til cancer | |
| DK3142689T3 (da) | Kombinationsbehandling til behandling af cancer med en koppevirus, som udtrykker et tumorantigen, og et monoklonalt antistof mod tim-3 | |
| DK3271389T3 (da) | Neutraliserende antistoffer mod gp120 og anvendelse deraf | |
| EA201790545A1 (ru) | Антитела и иммуноконъюгаты против her2 | |
| DK3508502T3 (da) | Kombination af anti-lag-3-antistoffer og anti-pd-1-antistoffer til behandling af tumorer | |
| DK3309174T3 (da) | ANTI-PD-L1-antistoffer og diagnostiske anvendelser deraf | |
| DK3166973T3 (da) | Immunstimulerende monoklonale antistoffer mod human interleukin-2 | |
| IL270729A (en) | Therapeutic anti-cd40 ligand antibodies | |
| EP3623809A4 (en) | CANCER DIAGNOSIS DEVICE | |
| DK3512882T3 (da) | Anti-c-met-antistoffer og antistoflægemiddelkonjugater deraf til effektiv tumorinhibering | |
| DK3154583T3 (da) | Humane monoklonale antistoffer mod gangliosid gd2 | |
| EP3635125A4 (en) | Guided combinational therapeutic antibody | |
| IL270855A (en) | Treatment paradigm for an anti-cd19 antibody and venetoclax combination treatment | |
| PL3679069T3 (pl) | Przeciwciała przydatne w diagnostyce nowotworów | |
| IL286504A (en) | Anti-cd73, anti-pd-l1 antibodies and chemotherapy for treating tumors | |
| IL282308A (en) | Novel cancer antigens and methods |